4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001144204-19-047722
10% owner bought 400,000 shares at $15.00 ($6,000,000)
- 10% owner acquired 1,868,718 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Redmile Group, LLC 10% owner | 2019-10-07 | Conversion | +1,868,718 | 1,868,718 | I | ||
| Redmile Group, LLC 10% owner | 2019-10-07 | Purchase | +400,000 | $15.00 | $6,000,000 | 2,268,718 | I |
| Derivatives | |||||||
| Redmile Group, LLC 10% owner | 2019-10-07 | Conversion · Series C Preferred Stock | −1,164,674 | 0 | I | ||
| Open-market purchases · 400,000 sh · avg $15.00 · $6,000,000 | |||||||
Loading xslF345X03/tv530719_4.xml…